US$ 25.62
effects of igf-1 lr3 IGF-1, the Cross Road the Nutritional, Inflammatory and Hormonal Pathways to Frailty IGF1-LR3 Peptide | Enhance Growth
Description
Eastell et al., 2016
Eltrombopag (Promacta), a platelet-enhancing drug indicated for the treatment of thrombocytopenia, has been shown to increase erythrocyte production in patients with aplastic anemia who were non-responders to immunosuppressants

We have demonstrated that the CSQ-tag enables the successful production of therapeutic scFvs, and this strategy is likely applicable to a broad range of recombinant proteins beyond scFvs

Kramarczyk et al

2B) (Izuishi et al

Gluck, S
